Antitumor activity of concurrent blockade of immune checkpoint molecules CTLA-4 and PD-1 in preclinical models.
Year: 2013
Type: conference-abstract
Source: Journal of Clinical Oncology
Institution: Bristol-Myers Squibb (United States)
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3011071920
